GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
Source: SeekingAlpha
2026-05-28 15:44:09 ET
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment May 28, 2026 10:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
GSK Plc
NASDAQ: GLAXF
GLAXF Trading
-2.13% G/L:
$24.664 Last:
5,912 Volume:
$25.20 Open:
GLAXF Latest News
GLAXF Stock Data
$123,941,620,346
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
